Acarbose: all 54 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Study of Acarbose in LongevityTerminatedNCT02953093Phase 2Results posted
• Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)CompletedNCT02865499Phase 2Results posted
• A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedNCT01709305Phase 4Results posted
• Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM PatientsCompletedNCT01490918Phase 4Results posted
• Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)CompletedNCT01181674Phase 4Results posted
• Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood ObesityTerminatedNCT00846521Phase 4Results posted
• CGM-Guided Acarbose for Painful Diabetic NeuropathyCompletedNCT07436585Phase 1
• Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 DiabetesStatus unknownNCT05629806Phase 3
• The Efficacy and Tolerability of Acarbose in Healthy IndividualsCompletedNCT05542849Phase 4
• Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)WithdrawnNCT05487859Phase 2
• Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and AcarboseCompletedNCT05035849Not applicable
• Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownNCT04287387Phase 4
• Bioequivalence Study for Acarbose/Metformin FDCCompletedNCT04065581Phase 1
• Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.Status unknownNCT03961659Not applicable
• Research of Intensive Metabolic Intervention Before Pregnancy in PCOSStatus unknownNCT03383068Phase 4
• Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.TerminatedNCT03380546Phase 3
• Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedNCT03359837Phase 4
• Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure PatientsCompletedNCT03349684Phase 3
• Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small IntestinesCompletedNCT03241303Not applicable
• Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes PatientsStatus unknownNCT02999841Phase 4
• Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 DiabetesStatus unknownNCT02605772Phase 4
• Human Oral Detection of Glucose OlygomersCompletedNCT02589353Phase 4
• Treatment of Hypoglycemia Following Gastric Bypass SurgeryCompletedNCT02527993Phase 4
• Research of Intensive Lifestyle Intervention for PCOS Patients With IGTCompletedNCT02446834Not applicable
• the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix InsulinStatus unknownNCT02438397Phase 4
• Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant PatientsCompletedNCT02355509Phase 4
• Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 DiabetesCompletedNCT02315495Phase 3
• Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male VolunteersCompletedNCT02211950Phase 1
• Acarbose, Postprandial Hypotension and Type 2 DiabetesCompletedNCT02043886Phase 2
• Acarbose and Older Adults With Postprandial HypotensionCompletedNCT01914133Phase 2
• Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery DiseaseCompletedNCT01863147Phase 4
• Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 DiabetesStatus unknownNCT01758471Phase 4
• Bioequivalence Study for Acarbose / Metformin FDCCompletedNCT01728740Phase 1
• A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mgCompletedNCT01554631Phase 1
• Early Diabetes Intervention ProgramCompletedNCT01470937Phase 4
• A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard TabletCompletedNCT01388153Phase 1
• Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)CompletedNCT01279512Phase 4
• A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes MellitusStatus unknownNCT01245166Phase 3
• The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
• Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary CareCompletedNCT01010100Phase 3
• Vildagliptin and Endothelium-dependent VasodilatationCompletedNCT01000688Phase 3
• Glucose Reduction by Early Acarbose Treatment in Basal InsulinCompletedNCT00970528Phase 4
• Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)Status unknownNCT00858676Phase 4
• Acarbose Cardiovascular Evaluation TrialCompletedNCT00829660Phase 4
• A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT00677521Phase 2
• Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM TrialCompletedNCT00629213Phase 3
• Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCompletedNCT00568074Phase 4
• AI(I)DA Acarbose and the Subclinical InflammationCompletedNCT00558883Phase 3
• Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 DiabetesCompletedNCT00551954Phase 3
• The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic PatientsCompletedNCT00437918Phase 4
• Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 DiabetesStatus unknownNCT00417950Not applicable
• Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DMCompletedNCT00417729Phase 4
• Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
• Acarbose and Secondary Prevention After Coronary StentingCompletedNCT00221156Phase 3

← Acarbose overview